Aedes aegypti female
Zika virus is a mosquito-borne flavivirus, transmitted primarily by Aedes aegypti mosquitoes (which do not live in Alaska). The most common symptoms of Zika virus are fever, rash, joint pain and conjunctivitis, which can occur from 3 to 12 days after exposure. The illness is usually mild, with only one out of five infected people developing symptoms. Symptoms usually last less than one week.
Outbreaks of Zika have occurred in Africa, Southeast Asia, the Pacific Islands, and the Americas, with Puerto Rico reporting its first case of locally-acquired disease in December 2015. Locally mosquito-transmitted Zika has not been confirmed in the United States, although it is being investigated at the curent time (July, 2016). Additionally, both laboratory acquired and sexually transmitted Zika has been reported in the United States. In 2007, a case of Zika was confirmed in an Alaskan who traveled to Yap, and in July, 2016 an out of state person was diagnosed with Zika while in Alaska. Over 50 Alaskans have been tested for Zika after travel to countries with Zika transmission, and all have tested negative.
See the Alaska Zika FAQ for more information.
Arbovirus infections (including Zika) are reportable conditions in Alaska. Providers are reminded to report all suspected Zika infections to the Alaska Section of Epidemiology (SOE) at (907) 269-8000.
Laboratory Testing for Zika in Alaska
Contact the Section of Epidemiology (907-269-8000) to arrange Zika specimen collection and testing; details are available here.
The CDC links either to the right or below provide the latest information on Zika Virus